Back to Cardiology
CardiologyvMEDPED 1995Evidence-Based

US (MEDPED) Diagnostic Criteria for Familial Hypercholesterolemia (FH)

Diagnoses familial hypercholesterolemia using age-specific total cholesterol cutoff values that vary based on family history of FH. The US MEDPED (Make Early Diagnosis to Prevent Early Death) criteria provide a simplified approach to FH diagnosis using only total cholesterol levels and family history.

Clinical Input Parameters

years
Range: 0 — 120 years
mg/dL
Range: 50 — 1000 mg/dL
Clinical Assessment
Awaiting Parameters
medped diagnosis
—Points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The US (MEDPED) Diagnostic Criteria for Familial Hypercholesterolemia (FH) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Age-specific total cholesterol cutoffs: - Age <20: 1st degree 220, 2nd degree 230, 3rd degree 240, general population 270 mg/dL - Age 20-29: 1st degree 240, 2nd degree 250, 3rd degree 260, general population 290 mg/dL - Age 30-39: 1st degree 270, 2nd degree 280, 3rd degree 290, general population 340 mg/dL - Age ≥40: 1st degree 290, 2nd degree 300, 3rd degree 310, general population 360 mg/dL Diagnosis: Positive if total cholesterol ≥ corresponding cutoff

Clinical Pearls & Practice Notes

  • The US MEDPED criteria use only total cholesterol and family history, making them simpler to apply than other FH diagnostic tools.
  • Lower cholesterol cutoffs are used when there is a family history of FH (1st, 2nd, or 3rd degree relatives).
  • These criteria were designed for population screening and early diagnosis to prevent early cardiovascular death.
  • Consider genetic testing and cascade screening of family members if criteria are met.
  • The MEDPED criteria may be less sensitive than the Dutch Lipid Clinic Network criteria but are easier to apply in clinical practice.

Evidence & Literature Citations

  1. Williams RR, Hunt SC, Schumacher MC, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria focused on the family history. Am J Cardiol. 1993;72(2):171-176.
  2. Stone NJ, Levy RI, Fredrickson DS, Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974;49(3):476-488.
  3. MEDPED Program. Make Early Diagnosis to Prevent Early Death (MEDPED). University of Utah. Available at: https://www.medped.org/

Score Interpretation Ranges

Tier 1≤ pts

Meets US MEDPED criteria for FH

Tier 2≤ pts

Does not meet US MEDPED criteria for FH

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.